Search clinical trials for: Drospirenone and ethinyl estradiol combination (Yasmin)

Total 528 results

University of California, San Francisco

Completed

Continuous Versus Cyclical OCP Use in PCOS (CCOUP)

Polycystic Ovary Syndrome

United States
Catholic University of the Sacred Heart

Unknown

Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Italy
Boehringer Ingelheim

Terminated

A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood

Healthy

Germany
ViiV Healthcare
GlaxoSmithKline

Terminated

A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.

HIV Infections | Infection, Human Immunodeficiency Virus

United States
Navy General Hospital, Beijing

Unknown

Oral Contraceptives as Infertility Treatments for Premature Ovarian Failure

Primary Ovarian Insufficiency | Menopause, Premature

China
Bayer

Completed

Yasmin Post Marketing Surveillance

Contraception

Korea, Republic of
Bayer

Completed

To Evaluate Compliance to Treatment Regimen (Rate of Deviations From the Prescribed Regimen) in Polish Females Treated With Different Low Dose Oral Contraceptives (DOC)

Contraception

Poland
University of North Carolina, Chapel Hill
Foundation of Hope, North Carolina

Terminated

Binge Eating & Birth Control

Binge-Eating Disorder | Bulimia Nervosa | Binge Eating | Eating Disorders

United States
Silva Arslanian
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study

Polycystic Ovary Syndrome

United States
Bayer

Completed

Effects of Counseling on the Continuation Rates and Compliance for Newly Prescribed Oral Contraceptives (Yasmin® or Any Other Oral Contraceptives (OC)

Contraception

Saudi Arabia, Jordan, Lebanon, Bahrain, Kuwait, Oman, Qatar, Hungary, Albania, Egypt, Kenya, Macedonia, The Former Yugoslav Republic of, United Arab Emirates
National Institute of Mental Health (NIMH)

Terminated

Treatment of Menstrually Related Disorders With Continuous v. Interrupted Oral Contraceptives

Depression | Premenstrual Dysphoric Disorder | Premenstrual Syndrome | PMS | PMDD

United States
Ain Shams Maternity Hospital

Unknown

Levonorgestrel-releasing Intrauterine System Versus a Low-dose Combined Oral Contraceptive for Management of Adenomyosis Uteri (LNG-IUDvsCOCs)

Adenomyosis

Egypt
University of Athens

Unknown

Continuous Versus Cyclic Oral Contraceptives for Endometriosis

Dysmenorrhea | Pelvic Pain | Endometrioma | Dyspareunia

Greece
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Non-Fasting Conditions

Healthy

United States
NewAmsterdam Pharma
Novum

Recruiting

Evaluate the Pharmacokinetics of a Combined Oral Contraceptive (COC) With and Without Obicetrapib

Healthy Volunteers

United States
Catholic University of the Sacred Heart

Completed

Effects of Drospirenone-ethinylestradiol and/or Metformin on Cardiovascular Risk in Hyperinsulinemic Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome

Italy
Teva Pharmaceuticals USA

Completed

Drospirenone/Ethinyl Estradiol (3 mg/0.02 mg) Tablets Under Fasting Conditions.

Healthy

United States
Bristol-Myers Squibb

Completed

A Study to Investigate the Effects of BMS-986278 on Drospirenone and Ethinyl Estradiol Drug Levels in Healthy Female Participants

Healthy Volunteers

Canada
Massachusetts General Hospital
Bayer

Completed

The Oral Contraceptive Pill for Premenstrual Worsening of Depression

Depression | Premenstrual Syndrome

United States
Massachusetts General Hospital
Bayer

Completed

Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne

Acne Vulgaris

United States
Istanbul Training and Research Hospital

Withdrawn

Comparison of Levonorgestrel Intrauterine System, Copper T Intrauterine Device and Oral Contraceptives on Life Quality

Contraceptive Methods Comparison

Turkey
AGUNCO Obstetrics and Gynecology Centre

Completed

Clinical, Metabolic and Endocrine Effects of the Treatment With Drospirenone and Ethinyl Estradiol Alone or in Combination With Myo-inositol in Young Women With Polycystic Ovary Syndrome (PCOS) and Insulin Resistance

Polycystic Ovary Syndrome | PCOS

Italy
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

Contraception
Massachusetts General Hospital
Bayer

Terminated

A Study to Examine the Safety and Efficacy of Drospirenone and Ethinyl Estradiol (YAZ) Versus Placebo In HS

Hidradenitis Suppurativa

United States
Bayer

Completed

Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers

Contraception

Finland, Estonia, Lithuania, Austria
NewGiza University
Ain Shams University

Not yet recruiting

The Association of Hormonal Intake and Demographic Factors With Breast Cancer Risk. An Egyptian Case-controlled Study

Observational Study
Tyumen State Medical Academy

Unknown

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Hyperandrogenism | Polycystic Ovarian Syndrome | Menstrual Irregularities

Russian Federation
Bayer

Completed

Effect of Angeliq on Blood Pressure (BP) in Postmenopausal Hypertensive Women

Hypertension | Postmenopause
Bio-innova Co., Ltd

Not yet recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.03 mg) Tablets Relative to Yasmin®

Healthy Subjects
Bio-innova Co., Ltd

Recruiting

Drospirenone (3 mg) + Ethinyl Estradiol (0.02 mg) Tablets Relative to Yaz®

Healthy Subjects

Thailand
Catholic University of the Sacred Heart

Completed

Effect of Two Different Dosages of Ethinyl-estradiol in Association With Drospirenone in Women With Polycystic Ovary Syndrome.

Polycystic Ovary Syndrome | Estro-progestin Drugs

Italy
Bayer

Completed

Angeliq Regulatory Post Marketing Surveillance (Angeliq rPMS)

Osteoporosis, Postmenopausal | Postmenopausal Period

Korea, Republic of
University of Rochester

Completed

Treatment of Adolescent Polycystic Ovary Syndrome (PCOS)

Polycystic Ovary Syndrome
Bayer

Completed

Efficacy and Safety Study for an Oral Contraceptive Containing Folate

Contraception | Neural Tube Defects | Oral Contraceptives (OC)

United States
Bayer

Completed

SH T00186 in the Treatment of Primary Dysmenorrhea

Primary Dysmenorrhea

Germany, United Kingdom
Janssen Research & Development, LLC

Terminated

A Study to Investigate the Interaction Between JNJ-64155806 and Ethinylestradiol/Drospirenone in Healthy Females

Healthy

United States
Guangdong Women and Children Hospital

Completed

Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS

PCOS

China
Northwestern University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Metabolic Syndrome in PCOS: Precursors and Interventions

Polycystic Ovary Syndrome | Metabolic Syndrome

United States
Bayer

Completed

Effects of Angeliq and Prempro on Blood Pressure and Sodium Sensitivity in Postmenopausal Women With Prehypertension

Hypertension | Postmenopause | Pre-Hypertension

United States
Women's Hospital School Of Medicine Zhejiang University

Recruiting

Aspirin for the Management of Endometriosis-associated Pelvic Pain

Pelvic Pain

China
Brigham and Women's Hospital
Bayer

Completed

Effect of Estradiol+Drospirenone Versus Estradiol+MPA on Endothelial Function

Cardiovascular Diseases

United States
University of North Carolina, Chapel Hill
National Institute of Mental Health (NIMH)

Completed

Continuous Oral Contraceptive Treatment in Premenstrual Dysphoric Disorder (PMDD) (PMDD)

Premenstrual Dysphoric Disorder

United States
St. Joseph's Healthcare Hamilton
McMaster University; Hamilton Academic Health Sciences Organization

Recruiting

Oral Contraceptives for Treating Premenstrual Dysphoric Disorder in Bipolar Disorder

Bipolar Disorder | Premenstrual Dysphoric Disorder

Canada
Bayer

Completed

Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D

Contraceptives, Oral

Netherlands
Peking Union Medical College Hospital
Peking Union Medical College

Unknown

The Role of Dysbiosis of Gut Microbiota in the Pathogenesis of PCOS.

Polycystic Ovary Syndrome

China
Fudan University

Recruiting

Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety (PCOS)

Depression, Anxiety | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries

China
Iuliu Hatieganu University of Medicine and Pharmacy

Unknown

Metformin+ Drospirenone/ethinylestradiol30µg and Flow-mediated Dilation in Polycystic Ovary Syndrome

Polycystic Ovary Syndrome | Endothelial Dysfunction

Romania
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Evaluate Ovarian Follicular Activity and Hormone Levels for DR-102 Compared to Two 28-Day Oral Contraceptives

Oral Contraceptive | Follicle Development | Ovarian Follicle | Follicle Count | Follicle Size

United States
Inonu University

Recruiting

The Effect of Polycystic Ovary Syndrome Treatment on Metabolomics

Polycystic Ovary Syndrome

Turkey
Bayer

Completed

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

Healthy

Germany

3

Subscribe